TITLE

High dose immunoglobulin IV treatment in adrenoleukodystrophy

AUTHOR(S)
Cappa, M; Bertini, E; del Balzo, P; Cambiaso, P; Di Biase, A; Salvati, S
PUB. DATE
November 1994
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Nov1994 Supp, Vol. 57, p69
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66105666

 

Related Articles

  • Crohn's disease.  // Geriatrics;Dec98, Vol. 53 Issue 12, p16 

    Announces that Infliximab (Remicade), an intravenous (IV) injectable chimeric Immunoglobulin Gamma (IgG) monoclonal antibody, was approved for the treatment of Crohn's disease. Recommended dose; Most common side effects.

  • INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY. Dhar, Sandipan // Indian Journal of Dermatology;Jan-Mar2009, Vol. 54 Issue 1, p77 

    The article discusses the application of intravenous immunoglobulin (i.v. IG) in dermatology. It explains that an i.v. IG is a sterile highly purified immunoglobulin G preparation that was developed from pooled human plasma and consists of over 95% of unmodified IgG. One study reported the...

  • Blistering rash in an older man. Ward, Nathaniel J.; MacVane, Casey Z. // Journal of Family Practice;Mar2013, Vol. 62 Issue 3, p151 

    The article focuses on the diagnosis and treatment of refractory and severe bullous pemphigoid (BP). It mentions that BP is an autoimmune and blistering skin disease that are common in women aged 60 and above. It adds that BP is caused by the development of autoantibodies against the...

  • CITATIONS AND CLINICIANS' NOTES: THERAPEUTICS.  // Current Medical Literature: Dermatology;2004, Vol. 9 Issue 2, p48 

    Presents clinicians' notes about treatment for skin problems. High-dose intravenous immunoglobulin treatment of scleromyxoedema; Treatment of refractory pemphigus vulgaris with rituximab; Use of T cell modulator for plaque psoriasis.

  • Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation — treatment with anti-D immunoglobulin. Lee, S J; Churchill, W Hallowell; Konugres, A; Gilliland, D G; Antin, J H // Bone Marrow Transplantation;1/15/97, Vol. 19 Issue 2, p173 

    A 38-year-old man developed idiopathic thrombocytopenic purpura (ITP) 8 months following allogeneic BMT while being treated for cGVHD with corticosteroids and tacrolimus (FK506). He received two courses of high-dose intravenous immunoglobulin (IvIG) which resulted in transient improvement. A...

  • A case of Stevens Johnson syndrome in child. Marginean, Cristina Oana; Baghiu, Maria Despina; Duicu, Carmen; Pitea, Ana Maria; Marginean, Claudiu // Romanian Journal of Pediatrics;2012, Vol. 61 Issue 2, p219 

    We present a 9-year-old boy with epilepsy refractory to previous treatment diagnosed with Stevens Johnson syndrome appeared after the introduction of Lamictal in treatment. The boy had fever, polymorphous exanthema, papulopustular erythematous, bullous generalized vesiculobullous elements and...

  • Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin. Ostronoff, M.; Ostronoff, F.; Coutinho, M.; Calixto, R.; Maior, A. P. Souto; Sucupira, A.; Florencio, R.; Tagliari, C. // Bone Marrow Transplantation;Apr2006, Vol. 37 Issue 8, p797 

    A letter to the editor is presented in response to the article "Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin," published online on March 6, 2006.

  • High-dose intravenous immunoglobulin therapy in dysimmune neuropathies. Nobile-Orazio, E.; Bersano, A. // Neurological Sciences;Apr2002 Supplement 1, Vol. 23, pS25 

    Investigates the role of high-dose intravenous immunoglobulin G (IVIg) therapy in the treatment of dysimmune neuropathies. Disorders caused by immune response directed against peripheral nerve antigens; Side effects of several immune therapies.

  • Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome. Choung, Bum-Su; Yoo, Wan-Hee // Rheumatology International;May2012, Vol. 32 Issue 5, p1353 

    Sjogren's syndrome (SS) is a systemic autoimmune disease characterized by xerophthalmia, xerostomia and extraglandular manifestations. Anemia, leukopenia, thrombocytopenia and lymphoproliferative disorders, including lymphoma are well-known extraglandular, hematological complications of SS. We...

  • Fatal outcome in a case of dermatomyositis and Hamman-Rich syndrome. Macía-Villa, C. C.; Guillén-Astete, C. A.; Larena-Grijalba, C.; Zea-Mendoza, A. // Acta Reumatológica Portuguesa;jul-set2014, Vol. 39 Issue 3, p270 

    We present the fatal outcome in a 31-year-old woman of Latin-American origin diagnosed with dermatomyositis. There were three months between death and the onset of symptoms. The initial presentation was normal dermatological symptoms to which were short - ly added clinical signs of effects on...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics